Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 5kWORD 18k
11 December 2018
E-006203-18
Question for written answer E-006203-18
to the Commission
Rule 130
Ramon Tremosa i Balcells (ALDE)

 Subject:  Pig meat and CETA
 Answer in writing 

Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin lists doxycycline as an authorised antibiotic in the EU, with a maximum residue limit of 0.1 parts per million (ppm). Doxycycline is widely used in the European pig farming sector and, as long as withdrawal periods are adhered to, there is no breach of the regulation.

Through its customs inspection agency, Canada recently made clear that it does not authorise the use of this substance and it has set a presence limit lower than 0.01 ppm for consignments of pig meat imported from EU Member States, which poses a serious problem for all such European exporters.

In view of that fact and taking into account the trade and health agreements between the EU and third countries, including Canada, what action will the Commission take to ensure that European pig products can continue to be sold on the Canadian market?

Original language of question: ES 
Last updated: 7 January 2019Legal notice